Загрузка...
COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
COVID-19 disease increases interleukin (IL)-1β release. Anti-IL-1-treatment is effective in IL-1-mediated autoinflammatory diseases (AID). This case series presents COVID-19 in patients with IL-1-mediated and unclassified AID with immunosuppressive therapy (IT). Patient 1 is a 34-year-old woman with...
Сохранить в:
| Опубликовано в: : | J Clin Med |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915607/ https://ncbi.nlm.nih.gov/pubmed/33562758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040605 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|